<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001662</url>
  </required_header>
  <id_info>
    <org_study_id>SM3-ME-13</org_study_id>
    <secondary_id>2013-000663-83</secondary_id>
    <secondary_id>H-3-2013-039</secondary_id>
    <nct_id>NCT02001662</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders</brief_title>
  <official_title>The Analgesic Efficacy of the Adductor Canal Blockade in High Pain Responders After Arthroscopic Knee Surgery - a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to explore the analgesic effect of Adductor Canal Blockade (a
      peripheral nerve block) in high pain responding patients after arthroscopic knee surgery. The
      investigators hypothesize that the nerve block will have an abrupt analgesic effect.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score during 45 degree flexion of the knee</measure>
    <time_frame>45 minutes after nerve block</time_frame>
    <description>Pain score during flexion of the knee 45 min. after nerve block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>0-90 min. after first nerveblock</time_frame>
    <description>pain score at rest: time 0,15,30,45,60,75,90 min. after first nerve block pain score during flexion of the knee: time 0,15,30,45,60,75,90 min. after first nerve block pain score during mobilisation (5m walk): 45 and 90 min after nerve block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle strength</measure>
    <time_frame>45 and 90 min after nerve block</time_frame>
    <description>patients accesses muscle strength during walk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>0-90 min after nerve block</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Arthroscopic Knee Surgery</condition>
  <arm_group>
    <arm_group_label>Intervention group, block no. 1 - Ropivacain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adductor-Canal-Block no.1: 30mL ropivacaine (7.5 mg/ml) when postoperative VAS-score is &gt; 40mm (on a 0-100 mm VAS-scale) during a 45 degree active flexion of the knee.
Adductor-Canal-Block no.2: after 45 min (t45) - 30mL isotonic saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group, block no. 1 - saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Adductor-Canal-Block no.1: 30mL isotonic saline when postoperative VAS-score is above 40mm (on a 0-100 mm VAS-scale) during a 45 degree active flexion of the knee.
Adductor-Canal-Block no.2: after 45 min (t45) - 30mL ropivacaine (7.5 mg/ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intervention group, block no. 1 - Ropivacain</intervention_name>
    <description>Intervention group: 1. block ropivacaine - 2. block saline</description>
    <arm_group_label>Intervention group, block no. 1 - Ropivacain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group: 1. block - saline</intervention_name>
    <description>Control group: 1. block saline - 2. block ropivacaine</description>
    <arm_group_label>Control group, block no. 1 - saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Arthroscopic knee surgery, if reconstruction of Anterior Cruciate Ligament only hamstring
        graft 18-80 years of age BMI 18-40 ASA I-III written Consent

        Exclusion Criteria:

        Unable to communicate in danish, allergic reactions toward any study medication pregnancy
        alcohol/drug abuse daily opioid consumption scin infection (injection site)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malene Espelund, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Amager Hospital, University of Copenhagen, Denmark</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen, Amager</state>
        <zip>2300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2013</study_first_posted>
  <last_update_submitted>December 5, 2013</last_update_submitted>
  <last_update_submitted_qc>December 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Malene Espelund</investigator_full_name>
    <investigator_title>MD,</investigator_title>
  </responsible_party>
  <keyword>Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)</keyword>
  <keyword>High pain responders</keyword>
  <keyword>Adductore Canal Block</keyword>
  <keyword>Analgesics</keyword>
  <keyword>Ultrasound guided nerve block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

